Report

Global Market Study: HPV - April 2022

MI4A produces vaccine-specific market studies, analyzing global demand and supply prospects for individual vaccines. The studies identify areas of risk for sustainable access to vaccine supply and define mitigating actions. This analysis focuses on HPV vaccines and was published in April 2022.

Languages

  • English

Publication year

2020

Publisher

WHO

Type

Report

Categories

  • Programme management

Diseases

  • HPV

Tags

  • MI4A
  • Planning, budgeting and financing

Topic references

EPI-CORE-MI4A

TitleAuthorYearTypeLanguage
Global Market Study: BCG Vaccine - May 2019World Health Organization (WHO)2019ReportEnglish
Global Market Study: Diphtheria and tetanus-containing vaccines - 2019World Health Organization (WHO)2019ReportEnglish
Global Market Study: HPV - April 2022World Health Organization (WHO)2020ReportEnglish
Global Market Study: Human Rabies vaccines - December 2020World Health Organization (WHO)2020ReportEnglish
Global Market Study: Measles-containing vaccines (MCV) - July 2020World Health Organization (WHO)2020ReportEnglish
Global Market Study: Meningococcal meningitis vaccines - 2019World Health Organization (WHO)2019ReportEnglish
Global Market Study: Pneumococcal Conjugate (PCV) and Polysaccharide (PPV) vaccines - June 2020World Health Organization (WHO)2020ReportEnglish
Global Market Study: Typhoid vaccines - 2020World Health Organization (WHO)2020ReportEnglish
Global Vaccine Market Report - 2023World Health Organization (WHO)2020ReportEnglish
MI4A Project OverviewWorld Health Organization (WHO)GuidanceEnglish
MI4A Vaccine Purchase DatabaseWorld Health Organization (WHO)DatasheetEnglish
Vaccine Price Report - 2017World Health Organization (WHO)2017ReportEnglish
Vaccine Pricing: Gavi Fully Self Financing and Accelerated Transition CountriesWorld Health Organization (WHO)2018ReportEnglish